Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1989; Volume 36,Issue 3
  • You have access
    Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.
    R B Clark, J Friedman, R A Dixon and C D Strader
    Molecular Pharmacology September 1989, 36 (3) 343-348;
  • You have access
    Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action.
    S N Abramson, Z Radic, D Manker, D J Faulkner and P Taylor
    Molecular Pharmacology September 1989, 36 (3) 349-354;
  • You have access
    ATP-sensitive binding of melittin to the catalytic domain of protein kinase C.
    C A O'Brian and N E Ward
    Molecular Pharmacology September 1989, 36 (3) 355-359;
  • You have access
    1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells.
    B Goz, P L Carl and T D Tlsty
    Molecular Pharmacology September 1989, 36 (3) 360-365;
  • You have access
    Binding of vinblastine to stabilized microtubules.
    W D Singer, M A Jordan, L Wilson and R H Himes
    Molecular Pharmacology September 1989, 36 (3) 366-370;
  • You have access
    Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
    Y H Hsiang, J B Jiang and L F Liu
    Molecular Pharmacology September 1989, 36 (3) 371-376;
  • You have access
    Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
    L M Bornheim and M A Correia
    Molecular Pharmacology September 1989, 36 (3) 377-383;
  • You have access
    Desensitization uncouples the formyl peptide receptor-guanine nucleotide-binding protein interaction in HL60 cells.
    K R McLeish, P Gierschik and K H Jakobs
    Molecular Pharmacology September 1989, 36 (3) 384-390;
  • You have access
    Inositol tetrakisphosphate mobilizes calcium from cerebellum microsomes.
    S K Joseph, C A Hansen and J R Williamson
    Molecular Pharmacology September 1989, 36 (3) 391-397;
  • You have access
    Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat.
    J K Nicholson, D P Higham, J A Timbrell and P J Sadler
    Molecular Pharmacology September 1989, 36 (3) 398-404;
  • You have access
    Determination of the association and dissociation rate constants of muscarinic antagonists on rat pancreas: rank order of potency varies with time.
    M Waelbroeck, J Camus and J Christophe
    Molecular Pharmacology September 1989, 36 (3) 405-411;
  • You have access
    Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.
    E Leung and R D Green
    Molecular Pharmacology September 1989, 36 (3) 412-419;
  • You have access
    Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    D R Poyner, N J Birdsall, C Curtis, P Eveleigh, E C Hulme, E K Pedder and M Wheatley
    Molecular Pharmacology September 1989, 36 (3) 420-429;
  • You have access
    Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    N W Kleckner and R Dingledine
    Molecular Pharmacology September 1989, 36 (3) 430-436;
  • You have access
    Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
    D Stickle and R Barber
    Molecular Pharmacology September 1989, 36 (3) 437-445;
  • You have access
    Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.
    K A Neve, R A Henningsen, J R Bunzow and O Civelli
    Molecular Pharmacology September 1989, 36 (3) 446-451;
  • You have access
    Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles.
    R Kaufman, G A Rogers, C Fehlmann and S M Parsons
    Molecular Pharmacology September 1989, 36 (3) 452-458;
  • You have access
    Growth of S49 cells in low concentrations of beta-adrenergic agonists causes desensitization.
    R Barber, T J Goka and R W Butcher
    Molecular Pharmacology September 1989, 36 (3) 459-464;
  • You have access
    An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    J Baumgold and A Drobnick
    Molecular Pharmacology September 1989, 36 (3) 465-470;
  • You have access
    Effect of anesthetics on calcium stores and membrane order of brain microsomes.
    L C Daniell and R A Harris
    Molecular Pharmacology September 1989, 36 (3) 471-477;
  • You have access
    Ceftriaxone binding to human serum albumin: competition with bilirubin.
    R Brodersen and A Robertson
    Molecular Pharmacology September 1989, 36 (3) 478-483;
  • You have access
    Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
    M K Bijsterbosch, G J Ziere and T J Van Berkel
    Molecular Pharmacology September 1989, 36 (3) 484-489;
  • You have access
    Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
    M Hasobe, J G McKee, H Ishii, M Cools, R T Borchardt and E De Clercq
    Molecular Pharmacology September 1989, 36 (3) 490-496;
  • You have access
    Enantioselective N-oxygenation of verapamil by the hepatic flavin-containing monooxygenase.
    J R Cashman
    Molecular Pharmacology September 1989, 36 (3) 497-503;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 36, Issue 3
1 Sep 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics